| Mark Erdrich, PHARMACIST | |
|
740 Otay Lakes Rd, Chula Vista, CA 91910-6915 | |
| (858) 373-7856 | |
| Not Available |
| Full Name | Mark Erdrich |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 740 Otay Lakes Rd, Chula Vista, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023424140 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 35327 (California) | Primary |
| 183500000X | Pharmacist | 8108 (Nevada) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark Erdrich, PHARMACIST 2940 Aber St, San Diego, CA 92117-2424 Ph: (858) 373-7856 | Mark Erdrich, PHARMACIST 740 Otay Lakes Rd, Chula Vista, CA 91910-6915 Ph: (858) 373-7856 |
News Archive
The allure of shedding unwanted pockets of fat with a series of simple injections, known as mesotherapy, sounds too good to be true - and it just might be. According to an ASPS Device & Technique Assessment (DATA) Committee report published in the April 15 issue of Plastic and Reconstructive Surgery® (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS), patients should be wary of mesotherapy until the safety and effectiveness of the procedure are confirmed.
Infants and very young children who are exposed to anesthesia may experience higher rates of learning disabilities and cognitive difficulties than children who are not exposed to anesthesia, according to research and emerging data presented during the SmartTots: Pediatric Anesthesia Neurotoxicity panel at the International Anesthesia Research Society annual meeting in Vancouver, B.C.
A team of researchers at Children's Hospital of Philadelphia affiliated with the CHOP Epilepsy Neurogenetics Initiative have combined clinical information with large-scale genomic data to successfully link characteristic presentations of childhood epilepsies with specific genetic variants.
OphthaliX announced today the completion of preclinical studies, showing that its CF101 drug candidate is efficacious in treating Anterior Uveitis
› Verified 2 days ago
Dr. Michael Elyea, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 619-397-3072 | |
Dr. Evelyn Hawson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 895 E H St, Chula Vista, CA 91910 Phone: 619-482-4405 | |
Ana Creps, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1376 3rd Ave, Chula Vista, CA 91911 Phone: 619-691-0662 Fax: 619-691-6811 | |
Richard Bonnoront, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 619-397-3060 | |
Shelby Wai Ling Lau, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1430 Eastlake Pkwy, Chula Vista, CA 91915 Phone: 619-591-7042 | |
Mary Mcdermott, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 3rd Ave, Suite A, Chula Vista, CA 91910 Phone: 619-420-7120 |